this is a very quiet thread, would appreciate hearing thoughts/opinions of other shareholders
it seems to me that this Co is approaching a critical stage in its development. Co announcements & media pieces make several references to Biomd being in discussions with a large medical co. we must be nearing commercialisaton.
Co seems to have plenty of cash to see it thru phase 2 trial and has a relatively low burn rate.
My understanding is that the product has a multitude of aplications from hearts to hernias, the potential market must be enourmous.
how about a few of you voyeurs out there throw your 2 bobs worth in and liven up this thread a bit and we may all learn something
BOD Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held